These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1379467)

  • 1. Effects of anti-TNF monoclonal antibody infusion in patients with hairy cell leukaemia.
    Huang D; Reittie JE; Stephens S; Hoffbrand AV; Brenner MK
    Br J Haematol; 1992 Jun; 81(2):231-4. PubMed ID: 1379467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5+, CD11c+, CD20+ hairy cell leukemia.
    Heimann PS; Vardiman JW; Stock W; Platanias LC; Golomb HM
    Blood; 1991 Apr; 77(7):1617-9. PubMed ID: 1706957
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.
    Robbins BA; Ellison DJ; Spinosa JC; Carey CA; Lukes RJ; Poppema S; Saven A; Piro LD
    Blood; 1993 Aug; 82(4):1277-87. PubMed ID: 7688993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alpha.
    Foa R; Guarini A; Francia di Celle P; Trentin L; Gillio Tos A; Bellone G; Carbone A; Attisano C; Massaia M; Raspadori D
    J Clin Oncol; 1992 Jun; 10(6):954-9. PubMed ID: 1588375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
    Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
    Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a paracrine pathway of B-cell stimulation in hairy cell leukaemia.
    Schmid M; Schrezenmeier H; Staib G; Porzsolt F
    Br J Haematol; 1995 May; 90(1):156-62. PubMed ID: 7786779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
    Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
    J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients.
    Falini B; Pileri SA; Flenghi L; Liberati M; Stein H; Gerli R; Minelli O; Martelli MF; Lauria F; Poggi S
    Br J Haematol; 1990 Dec; 76(4):460-8. PubMed ID: 1702309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
    Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
    J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
    J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody.
    Dancescu M; Wu C; Rubio M; Delespesse G; Sarfati M
    J Immunol; 1992 Apr; 148(8):2411-6. PubMed ID: 1373168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor alpha production by polymorphonuclear neutrophils treated with mouse anti-human CD19 monoclonal antibody.
    Nishimura M
    Cell Biochem Funct; 2004; 22(4):207-11. PubMed ID: 15248179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cell line from hairy-cell leukaemia producing interleukin-6 after Epstein-Barr virus immortalization.
    Tokioka T; Shimamoto Y; Nagumo F; Tadano J; Yamaguchi M
    Acta Haematol; 1994; 92(1):8-13. PubMed ID: 7985490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
    Robak T
    Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
    Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
    Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis.
    Miller ML; Fishleder AJ; Tubbs RR
    Am J Clin Pathol; 1991 Jul; 96(1):100-8. PubMed ID: 2069128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
    Lauria F; Lenoci M; Annino L; Raspadori D; Marotta G; Bocchia M; Forconi F; Gentili S; La Manda M; Marconcini S; Tozzi M; Baldini L; Zinzani PL; Foà R
    Haematologica; 2001 Oct; 86(10):1046-50. PubMed ID: 11602410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases.
    Defendenti C; Atzeni F; Malandrin S; Ardizzone S; Almasio PL; Saibeni S; Bezzio C; Bollani S; Salerno R; Declich P; Sarno Z; Bruno S; Talotta R; Sarzi-Puttini P
    Int Immunopharmacol; 2018 Jan; 54():329-335. PubMed ID: 29197269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
    Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
    Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.